Consensus Mustang Bio, Inc.

Equities

MBIO

US62818Q2030

Real-time Estimate Cboe BZX Other stock markets 10:28:18 10/05/2024 pm IST			5-day change	1st Jan Change
0.271 ^USD	+0.30%		-14.47%	-79.87%

02/05	Mustang Bio, Inc. announced that it has received $3.3 million in funding	CI
30/04	Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants	MT

Evolution of the average Target Price on Mustang Bio, Inc.

Price target over the last 5 years

History of analyst recommendation changes

7bed0c5ad7740d40565.EmM9-fVzGP1jN9fKdgxQik01N_vikZDAdJoEECr1H7w.JxtpvLBDTZkaVIf9A1wVxAsFUI212aeKJqgyYXqWePB8O2qajylUyQ4CpA~f2dfcdc372d24171af9e3db99b007507

Analyst Recommendations on Mustang Bio, Inc.

Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants	30/04	MT
BTIG Adjusts Price Target on Mustang Bio to $16 From $20, Maintains Buy Rating	15/23/15	MT
BTIG Raises Price Target on Mustang Bio to $20 From $4, Maintains Buy Rating	16/23/16	MT
B. Riley Adjusts Mustang Bio's Price Target to $10 From $4 After Model Updates, Reverse Stock Split; Keeps Buy Rating	30/23/30	MT
BTIG Adjusts Mustang Bio's Price Target to $4 From $8, Keeps Buy Rating	16/22/16	MT
Oppenheimer Adjusts Mustang Bio Price Target to $4 From $8, Maintains Outperform Rating	16/22/16	MT
B. Riley Securities Trims Mustang Bio's Price Target to $4 from $5, Keeps Buy Rating	14/22/14	MT
B. Riley Trims Mustang Bio's Price Target to $5 from $6 to Reflect Increased Long-Term Cost of Capital Amid Current Macro Conditions, Keeps Buy Rating	23/22/23	MT
B. Riley Lowers Mustang Bio's Price Target to $6 from $13 After Revising Cost Capital Assumptions, Keeps Buy Rating	24/22/24	MT
Mustang Bio Says Data From Cancer Treatment MB-106 Trial Shows Overall Response Rate of 95%	13/21/13	MT
Oppenheimer Adjusts Mustang Bio PT to $8 From $11, Maintains Outperform Rating	16/21/16	MT
MUSTANG BIO : BTIG Initiates Mustang Bio at Buy Rating With $11 Price Target	18/21/18	MT
MUSTANG BIO : Oppenheimer Adjusts Mustang Bio PT to $11 From $13, Maintains Outperform Rating	25/21/25	MT
MUSTANG BIO : B. Riley Reinstates Mustang Bio With Buy Rating, $13 Price Target	23/20/23	MT
MUSTANG BIO : B. Riley Adjusts Mustang Bio's Price Target to $13 From $9, Keeps Buy Rating	08/20/08	MT
Avenue Therapeutics : Biotech incubator taps investors through in-house brokerage	02/18/02	RE

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.2702 USD

Average target price

17.5 USD

Spread / Average Target

+6,376.68%

High Price Target

25 USD

Spread / Highest target

+9,152.41%

Low Price Target

10 USD

Spread / Lowest Target

+3,600.96%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Mustang Bio, Inc.

BTIG
B. Riley
Oppenheimer

Quarterly earnings - Rate of surprise

Company calendar